Teva Pharma AG - Sunitinib-Teva 37.5 mg, Hartkapseln | | 67781 | | 03 | | Sunitinib-Teva 37.5 mg | | Hartkapseln | | L01XE04 | | Sunitinib | | 15.02.2021 | | |
| Composition | sunitinibum 37.5 mg, mannitolum, povidonum K 25, carmellosum natricum conexum corresp. natrium max. 0.23 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. | Packungsbestandteile | | Capsules | | Principe actif | Concentr. |
---|
Sunitinib | 37.5 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Nigrum) | | | Ammoniae Solutio Concentrata | | | Carmellosum Natricum Conexum | | | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Kalii Hydroxidum | | | Lacca | | Drucktinte | Magnesii Stearas | | | Mannitol | | | Povidonum K | 25 | | Pro Capsula | | | Propylenglycol | | |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
003 | 28 | DDP | DDP | A | | Oui |
|
|